Skip to main content
Deciphera Pharmaceuticals, Inc. (DCPH)
NASDAQ: DCPH · IEX Real-Time Price · USD
14.65
+0.47 (3.31%)
Apr 26, 2024, 4:00 PM EDT - Market closed

Deciphera Pharmaceuticals Revenue

In the year 2023, Deciphera Pharmaceuticals had annual revenue of $163.36M with 21.87% growth. Revenue in the quarter ending December 31, 2023 was $48.29M with 32.88% year-over-year growth.

Revenue (ttm)
$163.36M
Revenue Growth
+21.87%
P/S Ratio
7.37
Revenue / Employee
$460,158
Employees
355
Market Cap
1.20B USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023163.36M29.32M21.87%
Dec 31, 2022134.04M37.89M39.41%
Dec 31, 202196.15M54.06M128.45%
Dec 31, 202042.09M17.09M68.35%
Dec 31, 201925.00M--
Dec 31, 20180--
Dec 31, 20170--
Dec 31, 20160--
Dec 31, 20150--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Pacira BioSciences 674.98M
Collegium Pharmaceutical 566.77M
Ironwood Pharmaceuticals 442.74M
Xencor 168.34M
4D Molecular Therapeutics 20.72M
Tarsus Pharmaceuticals 17.45M
Spyre Therapeutics 886.00K
Revenue Rankings

DCPH News

More News